Management of neonatal herpes simplex virus infection and exposure

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 99, Issue 3, 2014, Pages

  Pinninti, Swetha G ^a   Kimberlin, David W ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; VIDARABINE;

ANTIVIRAL THERAPY; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; CYTOPATHOGENIC EFFECT; DELIVERY; DISSEMINATED INTRAVASCULAR CLOTTING; EXPOSURE; FETAL SCALP ELECTRODE; GENITAL HERPES; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; LIVER FAILURE; MATERNAL DISEASE; NEWBORN DISEASE; PATIENT COMPLIANCE; POLYMERASE CHAIN REACTION; PREGNANCY; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROGNOSIS; RECURRENT INFECTION; RESPIRATORY FAILURE; REVIEW; RISK FACTOR; SEROPREVALENCE; TISSUE CULTURE; VIRUS TRANSMISSION;

ACYCLOVIR; GENITAL HERPES; NEONATAL HERPES; PCR;

ADULT; ANTIVIRAL AGENTS; FEMALE; HERPES SIMPLEX; HUMANS; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; MATERNAL EXPOSURE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROGNOSIS;

EID: 84898544331     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/archdischild-2013-303762     Document Type: Review

References (39)

1. Smith JS, Robinson NJ. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis. 2002;186(Suppl 1):S3-28.
2. Malkin JE. Epidemiology of genital herpes simplex virus infection in developed countries. Herpes 2004;11(Suppl 1):2A-23A.
3. Bernstein DI, Bellamy AR, Hook EW, et al. Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women. Clin Infect Dis 2013;56:344-51.
4. Gaytant MA, Steegers EA, van Laere M, et al. Seroprevalences of herpes simplex virus type 1 and type 2 among pregnant women in the Netherlands. Sex Transm Dis 2002;29:710-14. (Pubitemid 35266415)
5. Roberts CM, Pfister JR, Spear SJ. Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students. Sex Transm Dis 2003;30:797-800. (Pubitemid 37229492)
6. Kropp RY, Wong T, Cormier L, et al. Neonatal herpes simplex virus infections in Canada: results of a 3-year national prospective study. Pediatrics 2006;117:1955-62. (Pubitemid 46071239)
7. Whitley RJ, Corey L, Arvin A, et al. Changing presentation of herpes simplex virus infection in neonates. J Infect Dis 1988;158:109-16.
8. Bradley H, Markowitz LE, Gibson T, et al. Seroprevalence of Herpes Simplex Virus Types 1 and 2 - United States, 1999-2010. J Infect Dis 2014;209:315-7.
9. Kimberlin DW. The Scarlet H. J Infect Dis 2014;209:315-7.
10. Sheffield JS, Hill JB, Hollier LM, et al. Valacyclovir prophylaxis to prevent recurrent herpes at delivery: a randomized clinical trial. Obstet Gynecol 2006;108:141-7. (Pubitemid 44336857)
11. Watts DH, Brown ZA, Money D, et al. A double-blind, randomized, placebo-controlled trial of acyclovir in late pregnancy for the reduction of herpes simplex virus shedding and cesarean delivery. Am J Obstet Gynecol 2003;188:836-43. (Pubitemid 36332461)
12. Brown ZA, Benedetti J, Ashley R, et al. Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N Engl J Med 1991;324:1247-52.
13. Arvin AM, Hensleigh PA, Prober CG, et al. Failure of antepartum maternal cultures to predict the infant's risk of exposure to herpes simplex virus at delivery. N Engl J Med 1986;315:796-800. (Pubitemid 16014342)
14. Vontver LA, Hickok DE, Brown Z, et al. Recurrent genital herpes simplex virus infection in pregnancy: infant outcome and frequency of asymptomatic recurrences. Am J Obstet Gynecol 1982;143:75-84. (Pubitemid 12156075)
15. Tookey P, Peckham CS. Neonatal herpes simplex virus infection in the British Isles. Paediatr Perinat Epidemiol 1996;10:432-42. (Pubitemid 26366435)
16. Pascual A, Moessinger A, Gerber S, et al. Neonatal herpes simplex virus infections in Switzerland: results of a 6-year national prospective surveillance study. Clin Microbiol Infect 2011;17:1907-10.
17. Poeran J, Wildschut H, Gaytant M, et al. The incidence of neonatal herpes in The Netherlands. J Clin Virol 2008;42:321-5.
18. Koren A, Tasher D, Stein M, et al. Neonatal herpes simplex virus infections in Israel. Pediatr Infect Dis J 2013;32:120-3.
19. Kimberlin DW. Neonatal herpes simplex infection. Clin Microbiol Rev 2004;17:1-13. (Pubitemid 38120927)
20. Brown ZA, Wald A, Morrow RA, et al. Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 2003;289:203-9. (Pubitemid 36068708)
21. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. No. 82 June 2007. Management of herpes in pregnancy. Obstet Gynecol 2007;109:1489-98.
22. Chauhan SP, Hendrix NW, Berghella V, et al. Comparison of two national guidelines in obstetrics: American versus royal college of obstetricians and gynecologists. Am J Perinatol 2010;27:763-70.
23. Nahmias AJ, Josey WE, Naib ZM, et al. Perinatal risk associated with maternal genital herpes simplex virus infection. Am J Obstet Gynecol 1971;110:825-37.
24. Whitley RJ, Nahmias AJ, Soong SJ, et al. Vidarabine therapy of neonatal herpes simplex virus infection. Pediatrics 1980;66:495-501. (Pubitemid 10018429)
25. Whitley R, Arvin A, Prober C, et al. A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. Infectious Diseases Collaborative Antiviral Study Group. N Engl J Med 1991;324:444-9.
26. Whitley R, Arvin A, Prober C, et al. Predictors of morbidity and mortality in neonates with herpes simplex virus infections. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. N Engl J Med 1991;324:450-4.
27. Kimberlin DW, Lin CY, Jacobs RF, et al. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics 2001;108:230-8.
28. Kimberlin DW, Lin CY, Jacobs RF, et al. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics 2001;108:223-9.
29. Pickering L, Baker C, Kimberlin D, et al. In: Pickering L. ed. Red Book Report of the Committee on Infectious Diseases. 29th edn. Elk Grove Village, IL: American Academy of Pediatrics, 2012:398-408.
30. Diamond C, Mohan K, Hobson A, et al. Viremia in neonatal herpes simplex virus infections. Pediatr Infect Dis J 1999;18:487-9. (Pubitemid 29277609)
31. Kimberlin DW, Lakeman FD, Arvin AM, et al. Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis 1996;174:1162-7. (Pubitemid 26393892)
32. Kimura H, Futamura M, Kito H, et al. Detection of viral DNA in neonatal herpes simplex virus infections: frequent and prolonged presence in serum and cerebrospinal fluid. J Infect Dis 1991;164:289-93.
33. Malm G, Forsgren M. Neonatal herpes simplex virus infections: HSV DNA in cerebrospinal fluid and serum. Arch Dis Child Fetal Neonatal Ed 1999;81:F24-9. (Pubitemid 29307425)
34. Lewensohn-Fuchs I, Osterwall P, Forsgren M, et al. Detection of herpes simplex virus DNA in dried blood spots making a retrospective diagnosis possible. J Clin Virol 2003;26:39-48.
35. Kimberlin DW, Whitley RJ, Wan W, et al. Oral acyclovir suppression and neurodevelopment after neonatal herpes. N Engl J Med 2011;365:1284-92.
36. Nyquist AC, Rotbart HA, Cotton M, et al. Acyclovir-resistant neonatal herpes simplex virus infection of the larynx. J Pediatr 1994;124:967-71.
37. Rabalais GP, Nusinoff-Lehrman S, Arvin AM, et al. Antiviral susceptibilities of herpes simplex virus isolates from infants with recurrent mucocutaneous lesions after neonatal infection. Pediatr Infect Dis J 1989;8:221-3. (Pubitemid 19103630)
38. Kimberlin D, Powell D, Gruber W, et al. Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a phase I/II trial. Pediatr Infect Dis J 1996;15:247-54. (Pubitemid 26098476)
39. Kimberlin DW, Brady MT, Byington CL, et al. American Academy of Pediatrics Committee on Infectious Diseases, in conjunction with COFN and ACOG: Policy Statement - Guidance on management of neonates born to women with active genital herpes lesions. 2012.